SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-63 Cr | ₹63 Cr | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-63 Cr |
| Mar2024 | ₹63 Cr |
| Mar2023 | ₹0.58 Cr |
| Mar2022 | ₹-2.45 Cr |
| Mar2017 | ₹0.83 Cr |
How is Net Cash Inflow / Outflow of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-63 Cr | Negative | |
| Mar2024 | ₹63 Cr | 10,713.84 | |
| Mar2023 | ₹0.58 Cr | Positive | |
| Mar2022 | ₹-2.45 Cr | Negative | |
| Mar2017 | ₹0.83 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,272.8 Cr | -1.6% | -3.2% | -28.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.6% |
-3.2% |
-28.5% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses